ORLANDO – Intensive follow-up of patients who have
undergone surgery for hepatocellular carcinoma reduces deaths from
tumor recurrence and metastases, Dr. Timothy M. Pawlik said at a
symposium sponsored by the Society of Surgical Oncology.
Data from surveillance programs for hepatocellular
carcinoma (HCC) and empiric data from centers treating colorectal liver
metastases (CRLM) suggest that HCC tends to recur locally, and that
recurrent HCC and CRLM, if caught early, can be successfully controlled
with a variety of therapeutic options, said Dr. Pawlik, associate
professor of surgery and oncology, and hepatobiliary surgery program
director at Johns Hopkins Medical Center, Baltimore.
No comments:
Post a Comment